Zimmer Biomet Holdings

Warsaw, United Stateswww.zimmerbiomet.com/
Invested through
  • Triodos Impact Mixed Fund - Defensive
  • Triodos Impact Mixed Fund - Neutral
  • Triodos Impact Mixed Fund - Offensive
  • Triodos Euro Bond Impact Fund
  • Triodos Multi Impact Fund
  • Triodos Impact Strategy Fund - Defensive
  • Triodos Impact Strategy Fund - Balanced
  • Triodos Impact Strategy Fund - Offensive
Asset ClassesCorporate bonds
Impact strategyImpact Equities and Bonds
ISIN codeXS2079105891
Industry groupHealth Care Equipment & Services
Aligned with SDGs
  • Good health and well-being

Founded in 1927, Zimmer Biomet is the top global manufacturer of reconstructive implants used in knee or hip replacement surgery. The company makes a variety of other orthopedic devices including shoulder implants, bone and tissue grafting materials, sports medicine products, dental implant systems, spinal implants, and trauma products for broken bones (such as screws). Additionally, Zimmer Biomet makes medical equipment used in orthopedic surgeries, and related surgical products. The firm’s products are sold around the globe, primarily in the Americas (around 60% of revenues).

Investment rationale

Zimmer Biomet products and services contribute to improving the quality of life, for example by restoring the mobility of patients through knee and hip implants. By donating orthopedic implants around the globe, contributing to the improvement of healthcare in developing world.

Zimmer Biomet actively participates in the Carbon Disclosure Project (CDP), with a 2020 ranking of B. In 2020, the company publicly committed to setting a science-based target for greenhouse gas emissions. Additionally, eight of the company’s major manufacturing sites are zero waste to landfill, and the company continues to increase recycling as it reduces its landfill waste.